Actinium Pharmaceuticals
ATNM
#9862
Rank
C$60.49 M
Marketcap
C$1.94
Share price
-2.10%
Change (1 day)
3.84%
Change (1 year)

Actinium Pharmaceuticals (ATNM) - Cash on Hand

Cash on Hand as of June 2025 : C$83.01 Million

According to Actinium Pharmaceuticals's latest financial reports the company has C$83.01 Million in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Actinium Pharmaceuticals - Cash on Hand chart (from 2006 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31C$0.10 B2.87%
2023-12-31C$0.10 B-31.18%
2022-12-31C$0.14 B48.99%
2021-12-31C$99.18 M22.39%
2020-12-31C$81.04 M570.54%
2019-12-31C$12.08 M-35.11%
2018-12-31C$18.62 M-14.86%
2017-12-31C$21.87 M-20.67%
2016-12-31C$27.57 M-22.48%
2015-12-31C$35.57 M356.27%
2014-12-31C$7.79 M32.22%
2013-12-31C$5.89 M5.53%
2012-12-31C$5.58 M-3.7%
2011-12-31C$5.8 M3869383.37%
2010-12-31C$0 M-93.28%
2009-12-31C$0 M-17.21%
2008-12-31C$0 M16.83%
2007-12-31C$0 M325.47%
2006-12-31C$0 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Genocea Biosciences
GNCA
C$27.89 M-66.40%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
C$2.04 B 2,366.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
C$0.36 B 340.27%๐Ÿ‡บ๐Ÿ‡ธ USA